iRadimed Corporation (IRMD) is a publicly traded Healthcare sector company. As of September 8, 2026, IRMD trades at $84.31 with a market cap of $1.07B and a P/E ratio of 46.77. IRMD moved +1.04% today. Year to date, IRMD is -13.24%; over the trailing twelve months it is +17.47%. Its 52-week range spans $47.48 to $107.90. Analyst consensus is buy with an average price target of $120.00. Rallies surfaces IRMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
IRMD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. IRMD recently traded at $84.31. Market cap is $1.07B. P/E ratio is 46.77. Revenue is $86.34M.
| Metric | Value |
|---|---|
| Price | $84.31 |
| Market Cap | $1.07B |
| P/E Ratio | 46.77 |
| EPS | $1.81 |
| Dividend Yield | 0.20% |
| 52-Week High | $107.90 |
| 52-Week Low | $47.48 |
| Volume | 87.50K |
| Avg Volume | 0 |
| Revenue (TTM) | $86.34M |
| Net Income | $23.05M |
| Gross Margin | 75.86% |
1 analysts cover IRMD: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $120.00.